Overview
Sabine Gerull practices in Aarau, Switzerland. Ms. Gerull is rated as an Experienced expert by MediFind in the treatment of Disseminated Tuberculosis. Her top areas of expertise are Graft Versus Host Disease (GvHD), Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Aplastic Anemia, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 60 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Disseminated Tuberculosis.
Locations
Aarau, AG, Switzerland
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantMs. Gerull isDistinguished. Learn about Bone Marrow Transplant.
- Advanced
- Graft Versus Host Disease (GvHD)Ms. Gerull isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Gerull isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaMs. Gerull isExperienced. Learn about Anemia.
- Aplastic AnemiaMs. Gerull isExperienced. Learn about Aplastic Anemia.
- Disseminated TuberculosisMs. Gerull isExperienced. Learn about Disseminated Tuberculosis.
- Hemolytic AnemiaMs. Gerull isExperienced. Learn about Hemolytic Anemia.
- Hodgkin LymphomaMs. Gerull isExperienced. Learn about Hodgkin Lymphoma.